Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7320763

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,277,127,000 JPY
-1,299,827,000 JPY
Net cash provided by (used in) operating activities
-1,279,615,000 JPY
-1,303,049,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-1,132,000 JPY
-321,000 JPY
Other, net
JPY
-5,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
207,000 JPY
-326,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-37,000 JPY
Proceeds from issuance of bonds
JPY
400,000,000 JPY
Redemption of bonds
JPY
-400,000,000 JPY
Net cash provided by (used in) financing activities
1,853,195,000 JPY
882,617,000 JPY
Effect of exchange rate change on cash and cash equivalents
-1,065,000 JPY
-3,392,000 JPY
Net increase (decrease) in cash and cash equivalents
572,721,000 JPY
-424,150,000 JPY
Cash and cash equivalents
1,417,062,000 JPY
844,341,000 JPY
1,268,492,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.